SpringerLink
Log in

Magnetic Resonance Spectroscopy Studies in Schizophrenia

  • Chapter
  • First Online:
Neuroimaging in Schizophrenia

  • 875 Accesses

Abstract

MRS is a neuroimaging modality that provides information on brain biochemistry and microstructure. Research in schizophrenia using this modality is rapidly growing and meaningful insights have already been obtained. This chapter highlights both methodological and interpretation challenges for MRS research, and reviews the progress that has been made, with a particular focus on metabolites measured using proton and phosphorus MRS. This literature indicates that N-acetylaspartate concentrations are reduced in schizophrenia, reflecting abnormal neuronal integrity and function. This neuronal signal abnormality may be related to another major finding in MRS studies, and that is elevated glutamate-related metabolite signals. Elevated glutamate signaling is consistent with hypofunction of the NMDA receptor, which has been hypothesized in schizophrenia and which may give rise to downstream neuronal dysfunction. A separate line of research has identified deficient ATP production in schizophrenia, which may reflect reduced oxidative phosphorylation and a compensatory shift towards glycolysis. These bioenergetic abnormalities are also accompanied by redox imbalance, reflected in the NAD+/NADH ratio. Taken together, these findings are consistent with mitochondrial dysfunction in schizophrenia. This picture would be expected to impair information processing because brain activity is energetically expensive and reductions in energy supply are known to dysregulate neuronal function. MRS research has contributed insights into the biochemical correlates of schizophrenia and it is expected to play an even greater role in the future of our field due to ongoing technical improvements and higher magnet strengths.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now
Chapter
EUR 29.95
Price includes VAT (Germany)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
EUR 93.08
Price includes VAT (Germany)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
EUR 117.69
Price includes VAT (Germany)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info
Hardcover Book
EUR 160.49
Price includes VAT (Germany)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Bracken BK, Rouse ED, Renshaw PF, Olson DP. T2 relaxation effects on apparent N-acetylaspartate concentration in proton magnetic resonance studies of schizophrenia. Psychiatry Res. 2013;213:142–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Brandt AS, Unschuld PG, Pradhan S, Lim IA, Churchill G, Harris AD, et al. Age-related changes in anterior cingulate cortex glutamate in schizophrenia: a (1)H MRS study at 7 Tesla. Schizophr Res. 2016;172:101–5.

    Article  PubMed  PubMed Central  Google Scholar 

  • Bustillo JR. Use of proton magnetic resonance spectroscopy in the treatment of psychiatric disorders: a critical update. Dialogues Clin Neurosci. 2013;15:329–37.

    PubMed  PubMed Central  Google Scholar 

  • Bustillo JR, Chen H, Jones T, Lemke N, Abbott C, Qualls C, et al. Increased glutamine in patients undergoing long-term treatment for schizophrenia: a proton magnetic resonance spectroscopy study at 3 T. JAMA Psychiat. 2014;71:265–72.

    Article  CAS  Google Scholar 

  • Bustillo JR, Jones T, Chen H, Lemke N, Abbott C, Qualls C, et al. Glutamatergic and neuronal dysfunction in gray and white matter: a spectroscopic imaging study in a large schizophrenia sample. Schizophr Bull. 2017;43:611–9.

    PubMed  Google Scholar 

  • Chiappelli J, Rowland LM, Wijtenburg SA, Muellerklein F, Tagamets M, McMahon RP, et al. Evaluation of myo-inositol as a potential biomarker for depression in schizophrenia. Neuropsychopharmacology. 2015;40:2157–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chouinard VA, Kim SY, Valeri L, Yuksel C, Ryan KP, Chouinard G, et al. Brain bioenergetics and redox state measured by (31)P magnetic resonance spectroscopy in unaffected siblings of patients with psychotic disorders. Schizophr Res. 2017;187:11–6.

    Article  PubMed  PubMed Central  Google Scholar 

  • Chowdhury GM, Behar KL, Cho W, Thomas MA, Rothman DL, Sanacora G. (1)H-[(1)(3)C]-nuclear magnetic resonance spectroscopy measures of ketamine’s effect on amino acid neurotransmitter metabolism. Biol Psychiatry. 2012;71:1022–5.

    Article  CAS  PubMed  Google Scholar 

  • Coyle JT. NMDA receptor and schizophrenia: a brief history. Schizophr Bull. 2012;38:920–6.

    Article  PubMed  PubMed Central  Google Scholar 

  • Coyle JT, Basu A, Benneyworth M, Balu D, Konopaske G. Glutamatergic synaptic dysregulation in schizophrenia: therapeutic implications. Handb Exp Pharmacol. 2012;267–295.

    Google Scholar 

  • Da Silva T, Hafizi S, Andreazza AC, Kiang M, Bagby RM, Navas E, et al. Glutathione, the major redox regulator, in the prefrontal cortex of individuals at clinical high risk for psychosis. Int J Neuropsychopharmacol. 2018;21:311–8.

    Article  CAS  PubMed  Google Scholar 

  • de la Fuente-Sandoval C, Leon-Ortiz P, Azcarraga M, Stephano S, Favila R, Diaz-Galvis L, et al. Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy study. JAMA Psychiat. 2013;70:1057–66.

    Article  CAS  Google Scholar 

  • Do KQ, Cuenod M, Hensch TK. Targeting oxidative stress and aberrant critical period plasticity in the developmental trajectory to schizophrenia. Schizophr Bull. 2015;41:835–46.

    Article  PubMed  PubMed Central  Google Scholar 

  • Dogan AE, Yuksel C, Du F, Chouinard VA, Ongur D. Brain lactate and pH in schizophrenia and bipolar disorder: a systematic review of findings from magnetic resonance studies. Neuropsychopharmacology. 2018;43:1681–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Du F, Ongur D. Probing myelin and axon abnormalities separately in psychiatric disorders using MRI techniques. Front Integr Neurosci. 2013;7:24.

    Article  PubMed  PubMed Central  Google Scholar 

  • Du F, Zhu XH, Qiao H, Zhang X, Chen W. Efficient in vivo 31P magnetization transfer approach for noninvasively determining multiple kinetic parameters and metabolic fluxes of ATP metabolism in the human brain. Magn Reson Med. 2007;57:103–14.

    Article  CAS  PubMed  Google Scholar 

  • Du F, Zhu XH, Zhang Y, Friedman M, Zhang N, Ugurbil K, et al. Tightly coupled brain activity and cerebral ATP metabolic rate. Proc Natl Acad Sci U S A. 2008;105:6409–14.

    Article  PubMed  PubMed Central  Google Scholar 

  • Du F, Cooper A, Cohen BM, Renshaw PF, Ongur D. Water and metabolite transverse T2 relaxation time abnormalities in the white matter in schizophrenia. Schizophr Res. 2012;137:241–5.

    Article  PubMed  PubMed Central  Google Scholar 

  • Du F, Cooper AJ, Thida T, Shinn AK, Cohen BM, Ongur D. Myelin and axon abnormalities in schizophrenia measured with magnetic resonance imaging techniques. Biol Psychiatry. 2013a;74:451–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Du F, Cooper A, Lukas SE, Cohen BM, Ongur D. Creatine kinase and ATP synthase reaction rates in human frontal lobe measured by (3)(1)P magnetization transfer spectroscopy at 4T. Magn Reson Imaging. 2013b;31:102–8.

    Article  CAS  PubMed  Google Scholar 

  • Du F, Cooper AJ, Thida T, Sehovic S, Lukas SE, Cohen BM, et al. In vivo evidence for cerebral bioenergetic abnormalities in schizophrenia measured using 31P magnetization transfer spectroscopy. JAMA Psychiat. 2014;71:19–27.

    Article  CAS  Google Scholar 

  • Egerton A, Modinos G, Ferrera D, McGuire P. Neuroimaging studies of GABA in schizophrenia: a systematic review with meta-analysis. Transl Psychiatry. 2017a;7:e1147.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Egerton A, Bhachu A, Merritt K, McQueen G, Szulc A, McGuire P. Effects of antipsychotic administration on brain glutamate in schizophrenia: a systematic review of longitudinal (1)H-MRS studies. Front Psychiatry. 2017b;8:66.

    Article  PubMed  PubMed Central  Google Scholar 

  • Gonzalez-Burgos G, Cho RY, Lewis DA. Alterations in cortical network oscillations and parvalbumin neurons in schizophrenia. Biol Psychiatry. 2015;77:1031–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gonzalez-Toledo E, Kelley RE, Minagar A. Role of magnetic resonance spectroscopy in diagnosis and management of multiple sclerosis. Neurol Res. 2006;28:280–3.

    Article  CAS  PubMed  Google Scholar 

  • Goto N, Yoshimura R, Kakeda S, Nishimura J, Moriya J, Hayashi K, et al. Six-month treatment with atypical antipsychotic drugs decreased frontal-lobe levels of glutamate plus glutamine in early-stage first-episode schizophrenia. Neuropsychiatr Dis Treat. 2012;8:119–22.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Govindaraju V, Young K, Maudsley AA. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed. 2000;13:129–53.

    Article  CAS  PubMed  Google Scholar 

  • Hafizi S, Da Silva T, Meyer JH, Kiang M, Houle S, Remington G, et al. Interaction between TSPO-a neuroimmune marker-and redox status in clinical high risk for psychosis: a PET-MRS study. Neuropsychopharmacology. 2018;43(8):1700–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Iwata Y, Nakajima S, Plitman E, Mihashi Y, Caravaggio F, Chung JK, et al. Neurometabolite levels in antipsychotic-naive/free patients with schizophrenia: a systematic review and meta-analysis of (1)H-MRS studies. Prog Neuro-Psychopharmacol Biol Psychiatry. 2018;86:340–52.

    Article  CAS  Google Scholar 

  • Kantarci K, Petersen RC, Boeve BF, Knopman DS, Tang-Wai DF, O’Brien PC, et al. 1H MR spectroscopy in common dementias. Neurology. 2004;63:1393–8.

    Article  CAS  PubMed  Google Scholar 

  • Kegeles LS. Brain GABA function and psychosis. Am J Psychiatry. 2016;173:448–9.

    Article  PubMed  Google Scholar 

  • Keshavan MS, Anderson S, Pettegrew JW. Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. J Psychiatr Res. 1994;28:239–65.

    Article  CAS  PubMed  Google Scholar 

  • Kim SY, Cohen BM, Chen X, Lukas SE, Shinn AK, Yuksel AC, et al. Redox dysregulation in schizophrenia revealed by in vivo NAD+/NADH measurement. Schizophr Bull. 2017;43:197–204.

    Article  PubMed  Google Scholar 

  • Kraguljac NV, Reid M, White D, Jones R, den Hollander J, Lowman D, et al. Neurometabolites in schizophrenia and bipolar disorder—a systematic review and meta-analysis. Psychiatry Res. 2012;203:111–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kumar J, Liddle EB, Fernandes CC, Palaniyappan L, Hall EL, Robson SE, et al. Glutathione and glutamate in schizophrenia: a 7T MRS study. Mol Psychiatry. 2018.

    Google Scholar 

  • Lisman JE, Coyle JT, Green RW, Javitt DC, Benes FM, Heckers S, et al. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci. 2008;31:234–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Marjanska M, Emir UE, Deelchand DK, Terpstra M. Faster metabolite (1)H transverse relaxation in the elder human brain. PLoS One. 2013;8:e77572.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Marsman A, van den Heuvel MP, Klomp DW, Kahn RS, Luijten PR, Hulshoff Pol HE. Glutamate in schizophrenia: a focused review and meta-analysis of (1)H-MRS studies. Schizophr Bull. 2013;39:120–9.

    Article  PubMed  Google Scholar 

  • Marsman A, Mandl RC, Klomp DW, Bohlken MM, Boer VO, Andreychenko A, et al. GABA and glutamate in schizophrenia: a 7 T (1)H-MRS study. Neuroimage Clin. 2014;6:398–407.

    Article  PubMed  PubMed Central  Google Scholar 

  • Martens CR, Denman BA, Mazzo MR, Armstrong ML, Reisdorph N, McQueen MB, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD(+) in healthy middle-aged and older adults. Nat Commun. 2018;9:1286.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Matsuzawa D, Hashimoto K. Magnetic resonance spectroscopy study of the antioxidant defense system in schizophrenia. Antioxid Redox Signal. 2011;15:2057–65.

    Article  CAS  PubMed  Google Scholar 

  • Matsuzawa D, Obata T, Shirayama Y, Nonaka H, Kanazawa Y, Yoshitome E, et al. Negative correlation between brain glutathione level and negative symptoms in schizophrenia: a 3T 1H-MRS study. PLoS One. 2008;3:e1944.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Merritt K, Egerton A, Kempton MJ, Taylor MJ, McGuire PK. Nature of glutamate alterations in schizophrenia: a meta-analysis of proton magnetic resonance spectroscopy studies. JAMA Psychiat. 2016;73:665–74.

    Article  Google Scholar 

  • Ongur D, Jensen JE, Prescot AP, Stork C, Lundy M, Cohen BM, et al. Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania. Biol Psychiatry. 2008;64:718–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ongur D, Prescot AP, Jensen JE, Cohen BM, Renshaw PF. Creatine abnormalities in schizophrenia and bipolar disorder. Psychiatry Res. 2009;172:44–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ongur D, Prescot AP, Jensen JE, Rouse ED, Cohen BM, Renshaw PF, et al. T2 relaxation time abnormalities in bipolar disorder and schizophrenia. Magn Reson Med. 2010;63:1–8.

    Article  PubMed  Google Scholar 

  • Pettegrew JW, Keshavan MS, Minshew NJ. 31P nuclear magnetic resonance spectroscopy: neurodevelopment and schizophrenia. Schizophr Bull. 1993;19:35–53.

    Article  CAS  PubMed  Google Scholar 

  • Posporelis S, Coughlin JM, Marsman A, Pradhan S, Tanaka T, Wang H, et al. Decoupling of brain temperature and glutamate in recent onset of schizophrenia: a 7T proton magnetic resonance spectroscopy study. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018;3:248–54.

    Article  PubMed  Google Scholar 

  • Reid MA, Salibi N, White DM, Gawne TJ, Denney TS, Lahti AC. 7T proton magnetic resonance spectroscopy of the anterior cingulate cortex in first-episode schizophrenia. Schizophr Bull. 2019;45(1):180–9.

    Article  PubMed  Google Scholar 

  • Rothman DL, Novotny EJ, Shulman GI, Howseman AM, Petroff OA, Mason G, et al. 1H-[13C] NMR measurements of [4-13C]glutamate turnover in human brain. Proc Natl Acad Sci U S A. 1992;89:9603–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rowland LM, Bustillo JR, Mullins PG, Jung RE, Lenroot R, Landgraf E, et al. Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study. Am J Psychiatry. 2005;162:394–6.

    Article  PubMed  Google Scholar 

  • Rowland LM, Pradhan S, Korenic S, Wijtenburg SA, Hong LE, Edden RA, et al. Elevated brain lactate in schizophrenia: a 7 T magnetic resonance spectroscopy study. Transl Psychiatry. 2016;6:e967.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rowland LM, Demyanovich HK, Wijtenburg SA, Eaton WW, Rodriguez K, Gaston F, et al. Antigliadin antibodies (AGA IgG) are related to neurochemistry in schizophrenia. Front Psychiatry. 2017;8:104.

    Article  PubMed  PubMed Central  Google Scholar 

  • Schwerk A, Alves FD, Pouwels PJ, van Amelsvoort T. Metabolic alterations associated with schizophrenia: a critical evaluation of proton magnetic resonance spectroscopy studies. J Neurochem. 2014;128:1–87.

    Article  CAS  PubMed  Google Scholar 

  • Shirayama Y, Yano T, Takahashi K, Takahashi S, Ogino T. In vivo 31P NMR spectroscopy shows an increase in glycerophosphorylcholine concentration without alterations in mitochondrial function in the prefrontal cortex of medicated schizophrenic patients at rest. Eur J Neurosci. 2004;20:749–56.

    Article  PubMed  Google Scholar 

  • Shulman RG, Rothman DL, Behar KL, Hyder F. Energetic basis of brain activity: implications for neuroimaging. Trends Neurosci. 2004;27:489–95.

    Article  CAS  PubMed  Google Scholar 

  • Steen RG, Hamer RM, Lieberman JA. Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis. Neuropsychopharmacology. 2005;30:1949–62.

    Article  CAS  PubMed  Google Scholar 

  • Steullet P, Cabungcal JH, Monin A, Dwir D, O’Donnell P, Cuenod M, et al. Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: a “central hub” in schizophrenia pathophysiology? Schizophr Res. 2016;176:41–51.

    Article  CAS  PubMed  Google Scholar 

  • Steullet P, Cabungcal JH, Coyle J, Didriksen M, Gill K, Grace AA, et al. Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia. Mol Psychiatry. 2017;22:936–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Taylor R, Neufeld RW, Schaefer B, Densmore M, Rajakumar N, Osuch EA, et al. Functional magnetic resonance spectroscopy of glutamate in schizophrenia and major depressive disorder: anterior cingulate activity during a color-word Stroop task. NPJ Schizophr. 2015;1:15028.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Taylor R, Osuch EA, Schaefer B, Rajakumar N, Neufeld RW, Theberge J, et al. Neurometabolic abnormalities in schizophrenia and depression observed with magnetic resonance spectroscopy at 7 T. BJPsych Open. 2017;3:6–11.

    Article  PubMed  PubMed Central  Google Scholar 

  • Terpstra M, Vaughan TJ, Ugurbil K, Lim KO, Schulz SC, Gruetter R. Validation of glutathione quantitation from STEAM spectra against edited 1H NMR spectroscopy at 4T: application to schizophrenia. MAGMA. 2005;18:276–82.

    Article  CAS  PubMed  Google Scholar 

  • Thakkar KN, Rosler L, Wijnen JP, Boer VO, Klomp DW, Cahn W, et al. 7T proton magnetic resonance spectroscopy of gamma-aminobutyric acid, glutamate, and glutamine reveals altered concentrations in patients with schizophrenia and healthy siblings. Biol Psychiatry. 2017;81:525–35.

    Article  CAS  PubMed  Google Scholar 

  • Titov DV, Cracan V, Goodman RP, Peng J, Grabarek Z, Mootha VK. Complementation of mitochondrial electron transport chain by manipulation of the NAD+/NADH ratio. Science. 2016;352:231–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Valenzuela MJ, Sachdev P. Magnetic resonance spectroscopy in AD. Neurology. 2001;56:592–8.

    Article  CAS  PubMed  Google Scholar 

  • Wood SJ, Berger GE, Wellard RM, Proffitt TM, McConchie M, Berk M, et al. Medial temporal lobe glutathione concentration in first episode psychosis: a 1H-MRS investigation. Neurobiol Dis. 2009;33:354–7.

    Article  CAS  PubMed  Google Scholar 

  • **n L, Mekle R, Fournier M, Baumann PS, Ferrari C, Alameda L, et al. Genetic polymorphism associated prefrontal glutathione and its coupling with brain glutamate and peripheral redox status in early psychosis. Schizophr Bull. 2016;42:1185–96.

    Article  PubMed  PubMed Central  Google Scholar 

  • Yuksel C, Tegin C, O’Connor L, Du F, Ahat E, Cohen BM, et al. Phosphorus magnetic resonance spectroscopy studies in schizophrenia. J Psychiatr Res. 2015;68:157–66.

    Article  PubMed  Google Scholar 

  • Zhu XH, Lu M, Lee BY, Ugurbil K, Chen W. In vivo NAD assay reveals the intracellular NAD contents and redox state in healthy human brain and their age dependences. Proc Natl Acad Sci U S A. 2015;112:2876–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Psychotic Disorders Division, McLean Hospital, Belmont, MA, USA

    Dost Öngür

  2. Harvard Medical School, Boston, MA, USA

    Dost Öngür

Authors
  1. Dost Öngür
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dost Öngür .

Editor information

Editors and Affiliations

  1. Department of Psychiatry and Radiology, Brigham and Women’s Hospital, Boston, MA, USA

    Marek Kubicki

  2. Department of Psychiatry and Radiology, Brigham and Women’s Hospital, Boston, MA, USA

    Martha E. Shenton

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Öngür, D. (2020). Magnetic Resonance Spectroscopy Studies in Schizophrenia. In: Kubicki, M., Shenton, M. (eds) Neuroimaging in Schizophrenia . Springer, Cham. https://doi.org/10.1007/978-3-030-35206-6_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-35206-6_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-35205-9

  • Online ISBN: 978-3-030-35206-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation